• Oteseconazole (VT-1161): Optimizing Antifungal Assays for Ca

  2026-07-09

  Oteseconazole (VT-1161) is redefining antifungal research workflows by enabling precise, selective inhibition of Candida growth—even in fluconazole-resistant strains. This guide delivers actionable protocols, troubleshooting strategies, and insights from recent medicinal chemistry breakthroughs to boost reproducibility and impact in your laboratory.

• Low-Cost Microfluidic Mixers for Lipid Nanoparticle mRNA For

  2026-07-08

  Forrester et al. critically evaluate whether affordable microfluidic mixers can produce lipid nanoparticles (LNPs) for mRNA delivery with comparable quality to more advanced or manual methods. Their findings support the use of low-cost mixer designs for small-scale and high-throughput LNP research, ensuring accessibility without sacrificing encapsulation efficiency or expression outcomes.

• CDK9 Inhibitor (A3294): Technical Guidance for Lab Research

  2026-07-08

  CDK9 inhibitor (A3294) addresses the need for selective, non-cytotoxic inhibition of cyclin dependent kinase 9 in studies of transcription elongation and HIV-1 propagation. It should not be used for broad-spectrum CDK inhibition or protocols requiring long-term storage of working solutions due to its specificity and storage constraints.

• Trypsin as a Serine Protease: Applied Workflows and Innovati

  2026-07-07

  APExBIO's Trypsin (BA5744) elevates workflows in cell proliferation, wound healing research, and viral membrane fusion studies through its reliable, high-purity serine protease activity. This article decodes new evidence, protocol enhancements, and troubleshooting strategies to maximize experimental success in modern biomedical research.

• Nullscript: Advancing HDAC Inhibition in Translational Cardi

  2026-07-07

  Exploring Nullscript’s unique mechanistic profile as a histone deacetylase inhibitor, this thought-leadership article provides translational researchers with strategic insights for experimental design, competitive differentiation, and next-generation epigenetic modulation in cardiac injury models. By bridging evidence from preclinical studies with contemporary challenges in neurodegenerative and cancer research, we chart a path for rigorous, impactful translation.

• Z-VEID-FMK: Selective Caspase-6 Inhibitor for Apoptosis Rese

  2026-07-06

  Z-VEID-FMK is a selective, irreversible caspase-6 inhibitor used to dissect apoptotic mechanisms in neuronal and immune models. Its covalent binding profile and cell permeability make it a valuable tool for apoptosis assays and caspase activity measurement. Recent studies validate its efficacy in preclinical models of neuroinflammation and pain.

• Bradykinin B2 Receptors Inhibit Peristalsis in Guinea Pig Il

  2026-07-06

  This study demonstrates for the first time that bradykinin B2 receptors modulate and inhibit the peristaltic reflex in the guinea pig ileum, as evidenced by increased pressure thresholds for peristalsis upon B2 receptor activation. These findings expand our mechanistic understanding of gastrointestinal motility control and highlight new considerations for ACE inhibitor research.

• Refining In Vitro Drug Response Metrics in Cancer Research

  2026-07-05

  Schwartz's dissertation critically examines how standard in vitro assays may conflate cell proliferation arrest and cell death, leading to ambiguous interpretation of anticancer drug efficacy. By distinguishing between relative and fractional viability, this work clarifies drug response mechanisms, enabling more nuanced evaluation of compounds such as artemisinin derivatives in cancer models.

• BRD4 Inhibition, TXNIP Upregulation, and Ferroptosis Sensiti

  2026-07-04

  This study elucidates how BET bromodomain inhibitor JQ1 suppresses histone H4 UFMylation via TXNIP upregulation, thereby sensitizing solid tumor cells to ferroptosis. These findings bridge chromatin modification, cell cycle arrest, and ferroptosis susceptibility, providing mechanistic insight for BET inhibitor strategies in cancer research.

• Hexose Diphosphate (SKU M1436): Precision Tools for Metaboli

  2026-07-03

  Hexose diphosphate (SKU M1436) enables reproducible, high-sensitivity analysis in cell viability, proliferation, and inflammation assays. This article guides biomedical researchers through practical solutions to common workflow challenges, demonstrating how APExBIO's hexose diphosphate supports robust energy homeostasis and signal modulation.

• Amikacin Disulfate: Unlocking Mechanistic Precision in Trans

  2026-07-03

  This article explores how Amikacin disulfate, a semisynthetic aminoglycoside antibiotic, transforms translational research by offering mechanistic clarity in ribosomal inhibition and protein–drug interaction studies. Integrating recent discoveries on lysozyme–amikacin complexation, it provides actionable protocol guidance, strategic context, and a forward-looking perspective for researchers navigating bacterial resistance and advanced assay development.

• Triamcinolone (B1859): Technical Guidance for Research Use

  2026-07-02

  Triamcinolone (SKU B1859) is a synthetic glucocorticoid agonist designed to facilitate precise in vitro studies of glucocorticoid signaling, inflammation, and immunosuppression. It addresses the need for reproducible modulation of receptor-mediated pathways in a research context. This compound is not appropriate for diagnostic or clinical applications and requires careful handling to maintain data integrity.

• CB-839 (Telaglenastat): Unveiling Glutaminase 1 Inhibition i

  2026-07-02

  Explore the advanced scientific rationale and practical impact of CB-839 (Telaglenastat) as a selective glutaminase 1 inhibitor in cancer metabolism research. This in-depth review moves beyond protocol basics to reveal mechanistic insights and strategic assay applications grounded in recent epitranscriptomic discoveries.

• Tobramycin in Research: Advanced Kinetics and Assay Precisio

  2026-07-01

  Explore Tobramycin as an aminoglycoside antibiotic through the lens of in vitro kinetics, quantitative assay design, and nuanced resistance modeling. This article offers a unique, technically rigorous perspective for microbiology research.

• FCCP: Mitochondrial Uncoupler for HIF Pathway and Metabolic

  2026-07-01

  FCCP (carbonyl cyanide p-trifluoromethoxyphenylhydrazone) is a gold-standard lipophilic mitochondrial uncoupler widely used to dissect mitochondrial bioenergetics and inhibit hypoxia-inducible factor (HIF) pathways. Its precision in disrupting oxidative phosphorylation has made it indispensable in metabolic regulation and cancer research targeting HIF and VEGF signaling.

453 records 12/31 page Previous Next First page 上5页 1112131415 下5页 Last page